Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Metadata
Title
What Makes an Antipsychotic ‘Atypical’?
Should the Definition be Preserved?
Author
Dr John M. Kane
Publication date
01-05-1997
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 5/1997
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-199707050-00002

Other articles of this Issue 5/1997

CNS Drugs 5/1997 Go to the issue

Disease Management

Chemotherapy of Cerebral Malaria

Guest Commentaries

Talipexole

Drug Therapy

Serotonin 5-HT2 Receptor Antagonists

Disease Management

Plasma Drug Concentration Monitoring of Anticonvulsants

Leading Article

What Makes an Antipsychotic ‘Atypical’?

Guest Commentaries

Talipexole